José
Palacios Calvo
Profesor/a Titular Universidad
![Foto de José](/img/nophoto.png)
![Foto de Universidad Complutense de Madrid](/img/noimage_org.png)
Universidad Complutense de Madrid
Madrid, EspañaUniversidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (12)
2022
-
Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases
Cancers, Vol. 14, Núm. 5
-
Progression to lung fibrosis in severe COVID-19 patients: A morphological and transcriptomic study in postmortem samples
Frontiers in Medicine, Vol. 9
-
RNA SARS-CoV-2 Persistence in the Lung of Severe COVID-19 Patients: A Case Series of Autopsies
Frontiers in Microbiology, Vol. 13
2021
-
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888
-
Tumor mutational burden assessment in non-small-cell lung cancer samples: Results from the TMB 2 harmonization project comparing three NGS panels
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5
2018
-
Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH
Clinical and Translational Oncology, Vol. 20, Núm. 4, pp. 443-447
-
Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer
Revista Espanola de Patologia
2017
-
Neoadjuvant therapy with weekly nanoparticle albumin-bound paclitaxel for luminal early breast cancer patients: Results from the nabrax study (GEICAM/2011-02), a multicenter, non-randomized, phase ii trial, with a companion biomarker analysis
Oncologist, Vol. 22, Núm. 11, pp. 1301-1308
-
Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: A position statement of SEOM, SEAP and SEFH
Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 688-691
2010
-
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Molecular Cancer, Vol. 9
2008
-
JunD is involved in the antiproliferative effect of Δ
9
- tetrahydrocannabinol on human breast cancer cells
Oncogene, Vol. 27, Núm. 37, pp. 5033-5044
2006
-
Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
Cancer Research, Vol. 66, Núm. 13, pp. 6615-6621